J. Heijman

van Cauteren, Y. J. M., Lemmens, M. J. D. K., Bekkers, S. C. A. M., Kietselaer, B. L. J. H., Heijman, J., Theunissen, R. A. L. J., Rahel, B., Voorn, T., van Kuijk, S. M. J., Nijveldt, R., Vernooy, K., Wildberger, J. E., Mihl, C., & Smulders, M. W. (2025). Computed tomography angiography in the diagnosis of non-ST-elevation myocardial infarction: redefining our first line of defense. IJC Heart and Vasculature, 59, Article 101690. https://doi.org/10.1016/j.ijcha.2025.101690

Schuijt, E., Scherr, D., Plank, G., Schotten, U., & Heijman, J. (2025). Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. EP Europace, 27(1), Article euae304. https://doi.org/10.1093/europace/euae304

Cai, M., & Heijman, J. (2025). Challenges and Opportunities for Atrial Fibrillation Management. Cardiology Discovery. Advance online publication. https://doi.org/10.1097/CD9.0000000000000155

Cunha, P. S., Laranjo, S., Monteiro, S., Portugal, G., Guerra, C., Rocha, A. C., Pereira, M., Ferreira, R. C., Heijman, J., & Oliveira, M. M. (2024). The impact of atrial voltage and conduction velocity phenotypes on atrial fibrillation recurrence. Frontiers in Cardiovascular Medicine, 11, Article 1427841. https://doi.org/10.3389/fcvm.2024.1427841

Niskala, A., Heijman, J., Dobrev, D., Jespersen, T., & Saljic, A. (2024). Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation. British Journal of Pharmacology, 181(24), 4939-4957. https://doi.org/10.1111/bph.16470

Buonocunto, M., Lyon, A., Delhaas, T., Heijman, J., & Lumens, J. (2024). Electrophysiological effects of stretch-activated ion channels: a systematic computational characterization. The Journal of Physiology, 602(18), 4585-4604. https://doi.org/10.1113/JP284439

Bodi, I., Mettke, L., Michaelides, K., Hornyik, T., Meier, S., Nimani, S., Perez-Feliz, S., El-Battrawy, I., Bugger, H., Zehender, M., Brunner, M., Heijman, J., & Odening, K. E. (2024). Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models. Cardiovascular Research, 120(13), 1550-1561. https://doi.org/10.1093/cvr/cvae149

Fakuade, F. E., Hubricht, D., Möller, V., Sobitov, I., Liutkute, A., Döring, Y., Seibertz, F., Gerloff, M., Pronto, J. R. D., Haghighi, F., Brandenburg, S., Alhussini, K., Ignatyeva, N., Bonhoff, Y., Kestel, S., El-Essawi, A., Jebran, A. F., Großmann, M., Danner, B. C., ... Voigt, N. (2024). Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation. Circulation, 150(7), 544-559. https://doi.org/10.1161/CIRCULATIONAHA.123.066577

Trayanova, N. A., Lyon, A., Shade, J., & Heijman, J. (2024). Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation. Physiological Reviews, 104(3), 1265-1333. https://doi.org/10.1152/physrev.00017.2023

Heijman, J., & Dobrev, D. (2024). Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns. Circulation, 150(2), 128-131. https://doi.org/10.1161/CIRCULATIONAHA.124.070016